41 min

The change optimist Molecule to Market: Inside the outsourcing space

    • Life Sciences

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sébastien Ribault, Vice President & Head of End to End CDMO Services, Process Solutions at Merck Life Science.


Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sébastien, covering:


The ever-changing world of biotech and how things talked about 20 years ago are now becoming a reality for many treatments. 

Re-inventing the drug development process when faced with the 'Everest' of taking a covid treatment from bench to production in just nine months. 

Learning to ask those around you: "If you could do things differently - what would you do?" as a way of unlocking innovation and challenging the norm.

The wave of personalised medicines and treatments on the horizon and the need to develop the tools to bring down costs and make them more accessible.


With a PHD in Molecular & Cellular Biology, Sébastien has been in the biotech space for almost 25 years. He has spent the bulk of his career at Merck Life Science where he has progressed to the position of Head of End to End CDMO Services for Process Solutions.


Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! 


Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile, and generate leads in life sciences.


 

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sébastien Ribault, Vice President & Head of End to End CDMO Services, Process Solutions at Merck Life Science.


Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Sébastien, covering:


The ever-changing world of biotech and how things talked about 20 years ago are now becoming a reality for many treatments. 

Re-inventing the drug development process when faced with the 'Everest' of taking a covid treatment from bench to production in just nine months. 

Learning to ask those around you: "If you could do things differently - what would you do?" as a way of unlocking innovation and challenging the norm.

The wave of personalised medicines and treatments on the horizon and the need to develop the tools to bring down costs and make them more accessible.


With a PHD in Molecular & Cellular Biology, Sébastien has been in the biotech space for almost 25 years. He has spent the bulk of his career at Merck Life Science where he has progressed to the position of Head of End to End CDMO Services for Process Solutions.


Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also love a positive rating! 


Molecule to Market is sponsored and funded by ramarketing, an international content, design and digital agency that helps companies get noticed, raise profile, and generate leads in life sciences.


 

41 min